SCHEMBL2466696

SCHEMBL2466696

CNCCCCN(C(=O)O)c1cccc(Cn2nc(-c3cc(F)cc(F)c3)ccc2=O)c1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 18/20 0.55
▸ HDAC1 Q13547 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2467505 0.97 MET (0.56) METHDAC1
SCHEMBL2468835 0.94 MET (0.58) METHDAC1
SCHEMBL2468334 0.90 MET (0.63) MET
SCHEMBL2464380 0.89 MET (0.63) MET
SCHEMBL2466039 0.88 MET (0.54) MET
SCHEMBL1951449 0.88 MET (0.54) METHDAC1
SCHEMBL2468870 0.87 MET (0.46) METHDAC1
SCHEMBL2468084 0.87 MET (0.54) MET
SCHEMBL2491089 0.87 MET (0.59) MET
SCHEMBL2673295 0.87 MET (0.60) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1960370-B1 PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT MERCK PATENT GMBH (DE) 2011-10-05 — — EP claimed
Send feedback